Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anders Muusfeldt Birck, Liv Nordin Christensen, Mikkel H. Pedersen, Jens Olsen, Kelly D. Johnson, Goran Bencina, Thomas Holtkøtter Clausen & Carsten Schade Larsen. (2021) Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark. Expert Review of Vaccines 20:10, pages 1327-1337.
Read now
Read now
Francesco Paolo Bianchi, Pasquale Stefanizzi, Giuseppe Spinelli, Simona Mascipinto & Silvio Tafuri. (2021) Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis. Expert Review of Vaccines 20:3, pages 297-308.
Read now
Read now
Min-Joo Choi, Shin-On Kang, Jin-Jeong Oh, Seong-Beom Park, Min-Ja Kim & Hee-Jin Cheong. (2018) Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea. Human Vaccines & Immunotherapeutics 14:8, pages 1914-1922.
Read now
Read now
Yiling Jiang, Xiaoqin Yang, Kazuko Taniguchi, Tanaz Petigara & Machiko Abe. (2018) A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan. Journal of Medical Economics 21:7, pages 687-697.
Read now
Read now
Daniel M. Musher & Maria B. Rodriguez-Barradas. (2016) Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant. Human Vaccines & Immunotherapeutics 12:2, pages 331-335.
Read now
Read now
Ho Namkoong, Makoto Ishii, Yohei Funatsu, Yoshifumi Kimizuka, Kazuma Yagi, Takahiro Asami, Takanori Asakura, Shoji Suzuki, Testuro Kamo, Hiroshi Fujiwara, Sadatomo Tasaka, Tomoko Betsuyaku & Naoki Hasegawa. (2016) Theory and strategy for Pneumococcal vaccines in the elderly. Human Vaccines & Immunotherapeutics 12:2, pages 336-343.
Read now
Read now
Articles from other publishers (16)
Jia Guo, Haijun Zhang, Haonan Zhang, Xiaozhen Lai, Jiahao Wang, Huangyufei Feng & Hai Fang. (2023) Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study. Vaccine 41:3, pages 716-723.
Crossref
Crossref
Xiaodong Sun, Yuekun Tang, Xiaoying Ma, Xiang Guo, Zhuoying Huang, Jia Ren, Jing Qiu, Hongli Jiang & Yihan Lu. (2021) Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China. Frontiers in Public Health 9.
Crossref
Crossref
Anthony L Cunningham, Peter McIntyre, Kanta Subbarao, Robert Booy & Myron J Levin. (2021) Vaccines for older adults. BMJ, pages n188.
Crossref
Crossref
C. Chen, P. Beutels, J. Wood, R. Menzies, C.R. MacIntyre, P. McIntyre & A.T. Newall. (2018) Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. Vaccine 36:42, pages 6307-6313.
Crossref
Crossref
Sophie Marbaix, Willy E. Peetermans, Jan Verhaegen, Lieven Annemans, Reiko Sato, Annick Mignon, Mark Atwood & Derek Weycker. (2018) Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection. PLOS ONE 13:7, pages e0199427.
Crossref
Crossref
Alvaro Mitsunori Nishikawa, Ana Marli Christovam Sartori, Giulia Marcelino Mainardi, Angela Carvalho Freitas, Alexander Itria, Hillegonda Maria Dutilh Novaes & Patrícia Coelho de Soárez. (2018) Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older. Vaccine 36:19, pages 2510-2522.
Crossref
Crossref
Liv S. Nymark, Tarang Sharma, Alexander Miller, Ulrika Enemark & Ulla Kou Griffiths. (2017) Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Vaccine 35:49, pages 6828-6841.
Crossref
Crossref
Elizabeth T. Cafiero-Fonseca, Andrew Stawasz, Sydney T. Johnson, Reiko Sato & David E. Bloom. (2017) The full benefits of adult pneumococcal vaccination: A systematic review. PLOS ONE 12:10, pages e0186903.
Crossref
Crossref
Jung Yeon Heo, Yu Bin Seo, Won Suk Choi, Jacob Lee, Ji Yun Noh, Hye Won Jeong, Woo Joo Kim, Min Ja Kim, Hee Young Lee & Joon Young Song. (2017) Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea. PLOS ONE 12:5, pages e0177342.
Crossref
Crossref
Ricardo J. José & Jeremy S. Brown. (2017) Adult pneumococcal vaccination. Current Opinion in Pulmonary Medicine 23:3, pages 225-230.
Crossref
Crossref
James D. Chalmers, James Campling, Alison Dicker, Mark Woodhead & Harish Madhava. (2016) A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Daniel M. Musher. (2016) Should Committees That Write Guidelines and Recommendations Publish Dissenting Opinions?. Mayo Clinic Proceedings 91:5, pages 634-639.
Crossref
Crossref
Livio Garattini, Anna Padula & Milene Rangel Da Costa. (2015) Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?. PharmacoEconomics 34:3, pages 221-224.
Crossref
Crossref
Marie-Josée J. Mangen, Mark H. Rozenbaum, Susanne M. Huijts, Cornelis H. van Werkhoven, Douwe F. Postma, Mark Atwood, Anna M.M. van Deursen, Arie van der Ende, Diederick E. Grobbee, Elisabeth A.M. Sanders, Reiko Sato, Theo J.M. Verheij, Conrad E. Vissink, Marc J.M. Bonten & G. Ardine de Wit. (2015) Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. European Respiratory Journal 46:5, pages 1407-1416.
Crossref
Crossref
Selya-Hammer Carl, Fleming Douglas, Jiang Yiling, Durnall Hayley, Keeping Sam & Carroll Stuart. (2015) Co-Administration of PPV23 and Influenza Vaccines in England and Wales: A Study Based on the Royal College of General Practitioners Sentinel Surveillance Network. Journal of Vaccines and Immunology 1:1, pages 043-049.
Crossref
Crossref
Patrícia Coelho de Soárez, Ana Marli Christovam Sartori, Angela Carvalho Freitas, Álvaro Mitsunori Nishikawa & Hillegonda Maria Dutilh Novaes. (2015) Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil. PLOS ONE 10:6, pages e0130217.
Crossref
Crossref